Story perspectives
NHS Drug Prices Rise Amid Investment Crisis, Warns Vallance
9/25/2025
33 7
1 of 1
Story summary
- National Health Service (NHS) must raise drug prices to retain pharmaceutical investments, according to Lord Patrick Vallance.
- Nearly £2 billion in planned investments have been scrapped or paused this year by Merck and AstraZeneca.
- Eli Lilly described the UK as "probably the worst country in Europe" for drug prices.
- Health Secretary Wes Streeting confirmed ongoing pricing discussions with drug companies.
